OverviewChartProfileKey statisticsFinancialsNews
Derivatives
TraderScreen

Lonza/  CH0013841017  /

Singapore
-  - Chg. - Volume Bid9:32:27 AM Ask- Market Capitalization Dividend Y. P/E Ratio
-SGD - -
Turnover: -		 79.97Bid Size: 10 -Ask Size: - 63.67 bill.SGD - -
GlobeNewswire 06-14 Galapagos presents encouraging new data for CD19 CAR-T candidate GLPG5101 in non-Hodgkin lymphoma at...
GlobeNewswire 06-13 Repligen Announces CEO Transition Plan
GlobeNewswire 05-30 Galapagos and Adaptimmune sign clinical collaboration agreement with an option to exclusively licens...
GlobeNewswire 05-15 Galapagos and Blood Centers of America announce strategic collaboration to accelerate Galapagos’ dec...
GlobeNewswire 05-08 Vaxcyte Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 05-08 Maravai LifeSciences Reports First Quarter 2024 Financial Results
GlobeNewswire 04-04 Galapagos showcases innovative approach in hematological cancer care with clinical and translational...
GlobeNewswire 04-04 Acumen Pharmaceuticals Collaborates with Lonza to Advance Sabirnetug for the Treatment of Alzheimer’...
GlobeNewswire 02-27 Vaxcyte Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
GlobeNewswire 02-15 Galapagos presents at EBMT-EHA annual meeting 2024
GlobeNewswire 01-04 Galapagos enters into strategic collaboration agreement with Thermo Fisher Scientific to further exp...
GlobeNewswire 2023-12-19 Galapagos announces start of PAPILIO-1 Phase 1/2 multiple myeloma study of point-of-care manufacture...
GlobeNewswire 2023-12-09 Galapagos presents new encouraging data at ASH 2023 from ongoing CD19 CAR-T studies with GLPG5201 an...
GlobeNewswire 2023-12-07 Galapagos to Host KOL Event on December 10, 2023, at 11:00 AM PST to discuss new data presented at A...
GlobeNewswire 2023-12-07 Business Update
GlobeNewswire 2023-11-06 Vaxcyte Reports Third Quarter 2023 Financial Results and Provides Business Update
GlobeNewswire 2023-11-01 Dr. Hartmut Tintrup joins Cellbox Solutions GmbH as new CEO
GlobeNewswire 2023-10-19 Viralgen welcomes back Andy Holt as CCO
GlobeNewswire 2023-10-16 Vaxcyte and Lonza Expand Collaboration for Global Commercial Manufacturing of Broad-Spectrum Pneumoc...
GlobeNewswire 2023-10-02 Repligen Appoints Olivier Loeillot as President and Chief Commercial Officer
GlobeNewswire 2023-09-20 Oxford Biomedica Plc - INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2023
GlobeNewswire 2023-09-19 Galapagos appoints Simon Sturge to its Board of Directors
GlobeNewswire 2023-09-13 Culture Biosciences Appoints Darcy Birse as Chief Commercial Officer
GlobeNewswire 2023-09-07 Institutional Investor Launches 2023 Developed Europe & Emerging Emea Executive Team Rankings
GlobeNewswire 2023-09-05 Ascendis Pharma Reports Second Quarter 2023 Financial Results